Actively Recruiting
Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Led by University of Jordan · Updated on 2025-04-22
50
Participants Needed
1
Research Sites
160 weeks
Total Duration
On this page
Sponsors
U
University of Jordan
Lead Sponsor
A
Abdalla Awidi Abbadi, MD
Collaborating Sponsor
AI-Summary
What this Trial Is About
Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis
CONDITIONS
Official Title
Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Severe knee osteoarthrosis stage III or IV confirmed by X-ray
- Willing to participate and able to sign informed consent
You will not qualify if you...
- Knee joint subluxation beyond 20 degrees
- Use of oral anticoagulants or heparin therapy
- Heart failure or arrhythmia
- Body mass index greater than 35
- Uncontrolled diabetes mellitus
- Evidence of infectious diseases
- Active infection
- Malignancy
- Pregnancy
- Anemia below 11g/dl, thrombocytopenia below 100,000, or leucopenia below 3000
- Unreliable patients
- Non-resident of Jordan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cell Therapy Center
Amman, Jordan, 00962
Actively Recruiting
Research Team
H
Hanan Jafar, PhD
CONTACT
A
Abdallah Awidi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here